Annet Kirabo
Vanderbilt University Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Annet Kirabo as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:46 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT03753204 · Salt-Sensitivity and Immunity Cell ActivationVanderbilt University Medical Center · completed · High Blood Pressure, Salt; Excess, Inflammation · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Salt Mediated Cross Talk Between Lymphatic Vessels and Immune Cells in Kidney DiseaseR01DK135764 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2023 to 2026 · $726,267 awarded in 2026Same name and institution; not confirmed by an ID
- Salt Sensitivity of Blood pressure (SSBP) and Autoimmune Lupus (SLE)P01HL174442 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2025 to 2026 · $479,091 awarded in 2026Same name and institution; not confirmed by an ID
- The gut microbiome, metabolome and salt-sensitivity of blood pressureR01HL182899 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2026 · $874,014 awarded in 2026Same name and institution; not confirmed by an ID
- Immune Mechanisms of Salt-Sensitive hypertensionR01HL144941 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2021 to 2025 · $571,886 awarded in 2025Same name and institution; not confirmed by an ID
- Enhancing parasympathetic activity to reduce vascular oxidative stress and endothelial dysfunctionR01HL157584 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2022 to 2024 · $747,710 awarded in 2024Same name and institution; not confirmed by an ID
- Salt taste sensitivity, genetics and salt sensitivity of blood pressure in HIVR21TW012635 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2023 to 2024 · $169,543 awarded in 2024Same name and institution; not confirmed by an ID
- Deep phenotypic and functional characterization of salt-responsive immune cells in human salt senstive hypertension using CTE-seqR03HL155041 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2021 to 2022 · $86,500 awarded in 2022Same name and institution; not confirmed by an ID
- Role of Salt, Isoketal-modified Proteins and Dendritic Cells in HypertensionK01HL130497 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2016 to 2020 · $163,944 awarded in 2020Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:46 UTC. The ranking covers the 200 most relevant of 3 PubMed records, and a shared surname and initials can bring in a namesake. All 3 on PubMed
- Atomoxetine on neurogenic orthostatic hypotension: a randomized, double-blind, placebo-controlled crossover trial.Clin Auton Res · 20246 citationsRCR 1.7
- 4 citationsRCR 0.4
- Complete autonomic blockade reveals nitric oxide contribution to blood pressure regulation in obese Black women.Clin Auton Res · 20240 citationsRCR 0.0